SCAGO Sickle Cell Disease Research Studies in Ontario - Sickle Cell Awareness Group of Ontario

Vaccine Hesitancy in the Sickle Cell Disease/Black Community

Read More

Sickle Cell within the At-Risk Communities

Read More

How Many Sickle Cell Disease Patients Are there in Ontario?

Read More

Identifying hospitals in need of education to provide optimal care for patients living with Sickle Cell Disease in Ontario

Read More

scago.1

377

Follow us on Instagram

View

Save the Date! Let your voice be heard in this upcoming Sickle Cell Town Hall meeting

Date: Saturday, August 27| 11:00 A.M.- 1:00P.M.(EST)

The Sickle Cell Awareness Group of Ontario and Ontario Health will be co-hosting a town hall meeting to share information on the development of a quality standard for sickle cell disease. We also want to hear your concerns and gather your feedback to better the draft quality standard and patient guide.
Link in Bio!

#sicklecell #sicklecellawareness #sicklecellwarrior #sicklecelldisease #foryou #sicklecellspeaks

View

The launch of the industry alliance council of the SCAGO is today.

View

Paxlovid is a COVID-19 medication that has been approved in Canada for those who are at a high risk of severe complications from COVID-19. At the Sickle Cell Awareness Group of Ontario, we wish to provide you the necessary information to make an informed choice about your COVID-19-related care. Always consult a health professional to discuss if Paxlovid would be a good option for you.

Paxlovid est un médicament contre la COVID-19 qui a été approuvé au Canada pour les personnes à risque élevé de complications graves de la COVID-19. À the Sickle Cell Awareness Group of Ontario, nous souhaitons vous fournir les informations nécessaires pour faire un choix éclairé concernant vos soins liés à la COVID-19. Consultez toujours un professionnel de la santé pour savoir si Paxlovid serait une bonne option pour vous.

#covid19 #medication #askadoctor
#SickleCellAwareness #vaccine #stayinformed

Load More Follow us on Instagram